Related Experiment Video
Updated: Feb 15, 2026

08:43
Three-dimensional Inflammatory Human Tissue Equivalents of Gingiva
Published on: April 3, 2018
10.4K
Dysbiotic Biofilms Deregulate the Periodontal Inflammatory Response
E R Herrero1, S Fernandes1, T Verspecht1
11 Department of Oral Health Sciences, KU Leuven, Leuven, Belgium.
Journal of Dental Research
|February 4, 2018
Summary
Oral dysbiosis in periodontal disease leads to increased pathobiont virulence and heightened inflammatory responses. Dysbiotic biofilms significantly amplify immune reactions compared to homeostatic ones.
Area of Science:
- Oral microbiology
- Immunology
- Periodontal disease research
Background:
- Periodontal diseases stem from oral microbiota dysbiosis and immune deregulation.
- Commensal bacteria can suppress pathobionts via hydrogen peroxide (H₂O₂) production.
- Understanding how biofilm ecology shifts impact virulence and host response is crucial.
Purpose of the Study:
- To compare pathobiont virulence gene expression in homeostatic vs. dysbiotic biofilms.
- To analyze differences in host inflammatory response to these biofilms.
- To investigate virulence and inflammatory changes within the same oral microbial ecology.
Main Methods:
- Quantitative polymerase chain reaction (qPCR) for pathobiont quantification.
- Gene expression analysis of bacterial virulence and host inflammatory markers.
- Cytokine enzyme-linked immunosorbent assays (ELISAs) for protein-level analysis.
Main Results:
- Dysbiotic biofilms showed increased pathobiont outgrowth compared to homeostatic biofilms.
- Key virulence genes were upregulated in pathobionts within dysbiotic biofilms.
- Dysbiotic biofilms induced significantly higher expression of IL-6, IL-1β, TNF-α, MMP-8, and CXCL8 (IL-8) in host cells.
Conclusions:
- Induced dysbiotic biofilms, rich in pathobionts, exhibit heightened virulence.
- These dysbiotic biofilms provoke a substantially stronger inflammatory host response than homeostatic biofilms.
- The study highlights the critical role of microbial dysbiosis in driving periodontal inflammation.
Related Concept Videos
Inflammatory Response
17.1K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
17.1K
Inflammatory Response II: Inflammatory Exudate and Tissue Repair
8.1K
The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
8.1K
Inflammatory Response I: Vascular and Cellular
16.9K
The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
16.9K
Biofilms
1.6K
Biofilms are complex communities of microorganisms encased in a self-produced extracellular polysaccharide matrix attached to surfaces. These microbial consortia can include single or multiple species, providing enhanced survival benefits by forming organized, multilayered structures.The formation of biofilms occurs through four key stages: attachment, colonization, development, and dispersal.During attachment, free-swimming planktonic cells adhere to a surface, often facilitated by...
1.6K
Inflammatory Bowel Disease I: Ulcerative Colitis
1.2K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.2K
Inflammatory Bowel Disease V: Surgical Management
672
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
672

